BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiricozzi A, Gisondi P, Bellinato F, Girolomoni G. Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies. Vaccines (Basel) 2020;8:E769. [PMID: 33339348 DOI: 10.3390/vaccines8040769] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Kralj M, Jakovac H. Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report. Clin Case Rep 2021. [PMID: 33821193 DOI: 10.1002/ccr3.4010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Norimatsu Y, Norimatsu Y. A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis. Medical Mycology Case Reports 2022;36:19-22. [DOI: 10.1016/j.mmcr.2022.03.001] [Reference Citation Analysis]
3 Richi P, Yuste J, Navío T, González-Hombrado L, Salido M, Thuissard-Vasallo I, Jiménez-Díaz A, Llorente J, Cebrián L, Lojo L, Steiner M, Cobo T, Martín MD, García-Castro M, Castro P, Muñoz-Fernández S. Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases. Vaccines (Basel) 2021;9:203. [PMID: 33671007 DOI: 10.3390/vaccines9030203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Esposito M, Campanati A, Giunta A, Calianno G, Bianchi L, Diotallevi F, Offidani AM, Fargnoli MC. Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic. Dermatol Ther (Heidelb) 2022. [PMID: 35103934 DOI: 10.1007/s13555-022-00684-3] [Reference Citation Analysis]
5 Gisondi P, Geat D, Naldi L, Piaserico S. Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments. J Eur Acad Dermatol Venereol 2021;35:e361-2. [PMID: 33650226 DOI: 10.1111/jdv.17200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang C, Rademaker M, Tate B, Baker C, Foley P. SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group. Australas J Dermatol 2021;62:151-6. [PMID: 33786833 DOI: 10.1111/ajd.13593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gisondi P, Bellinato F, Girolomoni G. Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists. J Eur Acad Dermatol Venereol 2022;36:165-6. [PMID: 35037307 DOI: 10.1111/jdv.17854] [Reference Citation Analysis]
8 Fougerousse AC, Mery-Bossard L, Parier J, Taieb C, Bertolotti A, Maccari F; GEM ResoPso. Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey. Clin Cosmet Investig Dermatol 2021;14:389-93. [PMID: 33935509 DOI: 10.2147/CCID.S311269] [Reference Citation Analysis]
9 Simonetti O, Radi G, Molinelli E, Rizzetto G, Diotallevi F, Offidani A. Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management. Hum Vaccin Immunother 2021;17:3268-75. [PMID: 34170791 DOI: 10.1080/21645515.2021.1925502] [Reference Citation Analysis]
10 Caminati M, Guarnieri G, Senna G. Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? Vaccines (Basel) 2021;9:38. [PMID: 33440794 DOI: 10.3390/vaccines9010038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Musumeci ML, Caruso G, Trecarichi AC, Micali G. Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: A real life experience. Dermatol Ther 2021;:e15177. [PMID: 34699117 DOI: 10.1111/dth.15177] [Reference Citation Analysis]
12 Garcillán B, Salavert M, Regueiro JR, Díaz-castroverde S. Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review. Vaccines 2022;10:297. [DOI: 10.3390/vaccines10020297] [Reference Citation Analysis]
13 Rick J, Thompson AM, Hsiao JL, Liao W, Shi VY. Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns. J Dermatolog Treat 2021;:1-4. [PMID: 33494626 DOI: 10.1080/09546634.2021.1880543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]